Recording intelligenceAI-generated brief · check the source for context

Mitochondrial Transfer in Cancer Metastasis

1:02:03 recording · AUTO · 4 speakers

Listen to the original

Listen to the episode
Executive Summary AI
  • Cindy Leifer opens with a 2025 Nature paper, Nerve to Cancer Transfer of Mitochondria During Cancer Metastasis, in which glioblastoma cells throw tunneling nanotubules into neurons like a straw and siphon off mitochondria to feed their high metabolic rate.4:46
  • A second paper, Intercellular Nanotubes Mediate Mitochondrial Trafficking Between Cancer and Immune Cells (Nature Nanotechnology, 2022), shows cancer cells hijacking mitochondria from T cells, which are themselves highly energetic and switch to fast but inefficient glycolysis.9:41
  • The third paper, Immune Evasion Through Mitochondrial Transfer in the Tumor Microenvironment (Nature, 2023), finds cancer cells take working mitochondria from tumor-infiltrating lymphocytes and donate back mutant ones kept from mitophagy by USP30, leaving T cells homoplasmic, exhausted and senescent.12:42
  • Brianne Barker then presents a Science Advances paper from the University of Colorado, first-authored by her former lab member Uma Kinteti, called PD-L1-CD80 Interactions are Required for Intracellular Signaling Necessary for Dendritic Cell Migration.27:30
  • Anti-PD-L1 antibody stops dendritic cells migrating while anti-PD-1 does not, because PD-L1 must interact in cis with CD80 on the same dendritic cell, which explains why anti-PD-L1 fails against melanoma yet ameliorates psoriasis in mice.37:49

Brief overview

Cancer cells swap mitochondria to disarm T cells, and PD-L1's cis partnership with CD80 drives dendritic migration.

  1. Cancer cells steal good mitochondria and hand back broken onesTumour cells siphon working mitochondria from neurons and T cells, then donate mutant ones that resist mitophagy, leaving T cells exhausted.
  2. USP30 marks a possible therapeutic vulnerabilityUSP30 protects cancer mitochondria from degradation, so blocking nanotube or vesicle transfer alongside checkpoint therapy improved outcomes in the paper.
  3. PD-L1 needs CD80 on its own cell to signal migrationMixing CD80-deficient with PD-L1-deficient cells, or using soluble CD80, gave no migration — the cis pairing with intracellular domains is required.

Questions this recording answers

10 questions, each answered where it is said
How do cancer cells take mitochondria from the nerves around them?

Cancer cells make tunneling nanotubules that reach the neurons innervating them, pop the straw into the neuron and suck off its mitochondria. The 2025 Nature paper, Nerve to Cancer Transfer of Mitochondria During Cancer Metastasis, showed this in glioblastoma, where nerves sit right against the tumor cells.

Answered around 6:25
Why would a cancer cell need to steal mitochondria at all?

Cancer growth and metastasis is a high energy thing: the cells grow like mad and have a very high metabolic rate, so they demand high levels of mitochondria. They can duplicate their own, but they also simply steal them from nearby cells such as neurons.

Answered around 5:18
What does the cancer cell give the T cell in exchange?

It donates back its own defective, mutated mitochondria. The T cell takes them up, loses its ability to generate its own energy, and becomes exhausted and senescent. It is a dual benefit: the cancer gets good mitochondria and hands its foe the bad ones.

Answered around 12:18
Why are those transferred cancer mitochondria not recycled away?

Mechanistically, the cancer mitochondria carry an associated protein called USP30 that protects them from degradation, so the cancer cell limits mitophagy and keeps its mitochondrial biomass high. Once transferred, those mitochondria stay resistant to mitophagy inside the T cell, which therefore cannot turn them over.

Answered around 17:29
What is homoplasmy and why does it disable a T cell?

The T cell keeps turning over its own mitochondria on its normal schedule, but the transferred defective ones cannot be turned over. Its own all go away, leaving only defective mitochondria, a state they called homoplasmy, and the T cell becomes exhausted, senescent and poorly functional.

Answered around 18:17
Can anything be done therapeutically about this mitochondrial transfer?

They show some drugs can block extracellular vesicle release or block nanotube formation, and combined with checkpoint therapy they get better therapy. The idea is to prevent transfer of the worse mitochondria to the T cells, so the T cells keep their energy capacity and stay anti-tumor.

Answered around 20:16
Besides nanotubes, how do mitochondria move between cells?

They are also transferred by extracellular vesicles, gap junction channels and cell fusion; a cell can bud off its mitochondria and give them to someone else in the area. Horizontal mitochondrial transfer, HMT, happens normally and under pathological conditions, and has been known for twenty years.

Answered around 24:19
Why do anti-PD-1 antibodies work in cancer while anti-PD-L1 antibodies do not?

Blocking PD-L1 also blocks the cis interaction that dendritic cells need to migrate to the draining lymph node, so you inhibit the migration that brings antigen to T cells. Anti-PD-1 does not change migration. Nobody knew about this migration role until this paper.

Answered around 45:08
What does PD-L1 interact with on the same dendritic cell?

The antibody that blocks migration binds a site on PD-L1 previously associated with PD-L1 interacting with CD80, the B7-1 molecule, on the same dendritic cell. That cis interaction, not the usual trans interaction with PD-1 on another cell, is what the migration phenotype depends on.

Answered around 38:15
Where might an anti-PD-L1 antibody actually be clinically useful?

In a mouse psoriasis model driven by the toll-like receptor drug imiquimod, blocking PD-L1 with either the antibody or the mutation ameliorated the psoriasis; the mice showed no dendritic cell migration to the lymph node and fewer Th17 cells. Blocking migration helps in autoimmune and autoinflammatory settings.

Answered around 57:18
Key Quote

“But disinformation is when you purposely mislead people, like saying the polio vaccine kills more people than it helps, which is complete disinformation.”

— Vincent Racaniello, Mitochondrial Transfer in Cancer Metastasis, at 2:11▶ listen at 2:11
Key Quote

“So they want to steal the mitochondria from their neighboring cells.”

— Cindy Leifer, Mitochondrial Transfer in Cancer Metastasis, at 13:42▶ listen at 13:42
Key Quote

“So if they don't have CD80 and PD-L1 on the same cell, the cells can't migrate.”

— Brianne Barker, Mitochondrial Transfer in Cancer Metastasis, at 50:52▶ listen at 50:52
Key Quote

“But we could imagine situations where we would want to block dendritic cell migration.”

— Brianne Barker, Mitochondrial Transfer in Cancer Metastasis, at 56:19▶ listen at 56:19

Cite this

“Mitochondrial Transfer in Cancer Metastasis.” https://traffic.libsyn.com/secure/immune/Immune095.mp3. Transcript summary by WhipScribe, https://whipscribe.com/transcript-pages/mitochondrial-transfer-in-cancer-metastasis.html.

Report this page
What is wrong with this page?